Literature DB >> 10970937

Possible applications for dopaminergic agents following traumatic brain injury: part 1.

R D Zafonte1, J Lexell, N Cullen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10970937     DOI: 10.1097/00001199-200010000-00014

Source DB:  PubMed          Journal:  J Head Trauma Rehabil        ISSN: 0885-9701            Impact factor:   2.710


× No keyword cloud information.
  4 in total

1.  Dopamine D2-receptor-mediated increase in vascular and endothelial NOS activity ameliorates cerebral vasospasm after subarachnoid hemorrhage in vitro.

Authors:  Gail J Pyne-Geithman; Danielle N Caudell; Matthew Cooper; Joseph F Clark; Lori A Shutter
Journal:  Neurocrit Care       Date:  2008-09-20       Impact factor: 3.210

2.  Psychotropic Medication Use During Inpatient Rehabilitation for Traumatic Brain Injury.

Authors:  Flora M Hammond; Ryan S Barrett; Timothy Shea; Ronald T Seel; Thomas W McAlister; Darryl Kaelin; David K Ryser; John D Corrigan; Nora Cullen; Susan D Horn
Journal:  Arch Phys Med Rehabil       Date:  2015-08       Impact factor: 3.966

3.  BPSD following traumatic brain injury.

Authors:  Renato Anghinah; Fabio Rios Freire; Fernanda Coelho; Juliana Rhein Lacerda; Magali Taino Schmidt; Vanessa Tomé Gonçalves Calado; Jéssica Natuline Ianof; Sergio Machado; Bruna Velasques; Pedro Ribeiro; Luis Fernando Hindi Basile; Wellingson Silva Paiva; Robson Luis Amorim
Journal:  Dement Neuropsychol       Date:  2013 Jul-Sep

4.  Placebo-controlled trial of oral amantadine and zolpidem efficacy on the outcome of patients with acute severe traumatic brain injury and diffuse axonal injury.

Authors:  Sajad Shafiee; Saeed Ehteshami; Mahmood Moosazadeh; Saeed Aghapour; Kaveh Haddadi
Journal:  Caspian J Intern Med       Date:  2022
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.